ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: health insurance

Reading Rheum

Daniel Hal Solomon, MD, MPH; Joan M. Von Feldt, MD;  |  November 1, 2007

Handpicked Reviews of Contemporary Literature

Filed under:ConditionsResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Clinical researchHYDROXYCHLOROQUINELiteratureReading RheumRheumatoid Arthritis (RA)Steroidsystemic lupus erythematosus (SLE)

National HMO Class-Action Case Settled

Staff  |  November 1, 2007

The latest development in the healthcare class-action settlement will affect approximately 900,000 physicians (and some major state medical societies) who may be eligible to receive compensation from the settlement – as long as they file a claim. The case has been called “historic” by those representing both physicians and insurance companies.

Filed under:From the CollegeLegal UpdatesPractice Support Tagged with:Health Insuranceinsurance plansmanaged carePractice ManagementReimbursement

ACR Attends AMA House of Delegates

Staff  |  September 1, 2007

On Saturday, June 23, 2007, the American Medical Association (AMA) House of Delegates convened in Chicago; the meeting’s theme was advocacy. The ACR was represented by its delegate Melvin Britton, MD, and alternate delegate Gary Bryant, MD.

Filed under:From the CollegeLegislation & AdvocacyQuality Assurance/Improvement Tagged with:AdvocacyAmerican Medical Association (AMA)CongressLegislationPoliticsQuality

ACR Board Lobbies Congress

Staff  |  July 1, 2007

ACR Board of Directors members recently spent time in Washington, D.C., discussing rheumatology-related issues with members of Congress, including Sen. Edward M. “Ted” Kennedy (D-Mass.). The senior senator from Massachusetts is the chair of the Senate Health, Education, Labor, and Pensions Committee, which oversees health legislation that affects rheumatologists.

Filed under:From the CollegeLegislation & Advocacy Tagged with:AdvocacyCongressLegislationPolitics

Medicare D-lemmas

Ann Kepler  |  January 1, 2007

Rheumatologists and patients report mixed experiences with the new prescription drug benefit

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingHealth InsuranceMedicarePractice ManagementReimbursementrheumatologist

Rheumatology Influencers: Dr. Hirsh Advocates for Physicians & Patients

Linda Childers  |  October 8, 2025

Dr. Marc Hirsch reflects on a career dedicated to advocating for physicians, providing patient-centered care & advancing medical education.

Filed under:GuidanceLegislation & AdvocacyPractice SupportProfiles Tagged with:Dr. Marc HirshMedicare Physician Fee Schedule (MPFS)physician payment reformPrivate practiceRheumatology Influencersscope of practice

What Clinicians Should Know About Midfoot Osteoarthritis

Yvonne M. Golightly, PT, MS, PhD, Jill Halstead, BSc, MSc, PhD, MRCPod, John B. Arnold, PhD, Lara S. Chapman, MSc, BPod, Catherine J. Bowen, PhD, BPod, Marian T. Hannan, DSc, MPH, Hylton B. Menz, PhD, BPod, Kade L. Paterson, PhD, BPod, BAppSci(Hons) & Martin J. Thomas, PhD, MCSP  |  October 8, 2025

Midfoot OA experts offer an overview of a common, but under-recognized, form of OA, & discuss quality of life impacts, treatments, clinical evaluation procedures & the critical need for further research.

Filed under:ConditionsGuidanceInterprofessional PerspectiveOsteoarthritis and Bone DisordersResearch Rheum Tagged with:DisparitiesExercisefootimagingmidfoot oteoarthritisNSAIDsorthoticsPainpodiatryquality of life

Rheumatology Influencers: Dr. Dave Has a Passion for Giving Back

Linda Childers  |  September 9, 2025

Dr. Amish Dave discusses how his volunteer, advocacy & public outreach work stem from his greater commitment to community & helping others.

Filed under:CareerLegislation & AdvocacyPractice SupportProfessional TopicsProfilesWorkforce Tagged with:AdvocacyDr. Amish J. Davefellowshiphealth disparitiesLeadershipprior authorizationpublic healthRheumatology InfluencersVolunteerworkforce shortage

3 AC&R Study Summaries: Avoidable RA Hospitalizations, Psoriasis to Psoriatic Arthritis Transition, & Neighborhood Conditions in Childhood Lupus

Arthritis Care & Research  |  September 8, 2025

New studies reveal predictors for avoidable RA hospitalizations, PsA transition in psoriasis & the impact of neighborhood on childhood lupus.

Filed under:ConditionsPsoriatic ArthritisResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RBiomarkersC-reactive proteinCardiovascular diseasechildhood-onset SLEcomorbiditiesDisparitieshospitalizedPediatric RheumatologyPsA Resource CenterPsoriasisRA Resource CenterReading RheumSLE Resource Centersocioeconomic

How the Experts Treat Sjögren’s Disease

Samantha C. Shapiro, MD  |  August 26, 2025

With no FDA-approved drugs for Sjögren’s disease, experts share strategies for managing fatigue, arthritis, dryness, and systemic issues.

Filed under:Biologics/DMARDsConditionsDrug UpdatesSjögren’s Disease Tagged with:Clinical Practice GuidelinesDry eyeDry MouthfatigueHYDROXYCHLOROQUINEInterstitial Lung DiseaseMethotrexateneuropathyshared decision makingSjögren’s Disease supplement

  • « Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • 55
  • …
  • 118
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences